autologous dendritic cell/myeloma fusion vaccine
A therapeutic cancer vaccine consisting of autologous dendritic cells (DCs) fused with patient-derived plasma cell (multiple) myeloma cells with potential immunostimulatory and antineoplastic activities. Upon administration, autologous DC/multiple myeloma fusions stimulate both helper and cytotoxic T-lymphocyte (CTL) responses through the presentation of internalized and newly synthesized tumor associated antigens (TAAs). This may promote cellular and humoral antitumor immune responses in patients with plasma cell myeloma.
| Synonym: | autologous DC/multiple myeloma fusions DC/MM fusion vaccine DC/MM fusions DC/multiple myeloma fusions DC/plasma cell myeloma fusion |
|---|